Active, not recruiting
Safety and Efficacy of Xalkori ROS1
NCT03375242
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Pfizer Tokyo, Japan